# AI Infrastructure Is Eating Everything — Where to Hide and Where to Hunt — May 22, 2026
*Your daily momentum scan, brought to you by [SignalDeck.live](https://signaldeck.live).*
The cleanest setup on the board today isn’t a small-cap moonshot — it’s **IBM**, the mainframe dinosaur that nobody invited to the AI party. Relative strength 90, climbing at +4.3 points a day, and a volume reading **3.5x its normal session** as institutions hit the bid in real time. Meanwhile semiconductors have gone full mania — every name up 50% to 185% on the month — and chasing them now is paying retail prices for what smart money already owns. The trade is rotating *adjacent* to the heat, not into it.
## The Top Calls
**IBM (International Business Machines)** · IT Services · RS 91 · Vel +4.3/day · Month +13% — The risk-adjusted standout of the day. Mainframe + consulting + watsonx AI services means real free cash flow underneath the narrative, not just promise. Today’s volume confirmation is the tell: **3.5x normal session volume** on a Phase 2 breakout means institutions are buying in size, not retail chasing a chart. Month-over-month only +13% means the move is not extended — there’s still runway. Watch the $290-300 zone for continuation, and watch for any pullback toward the 21-day moving average as add-on entry.
**ServiceNow (NOW)** · Application Software · RS 91 · Vel +4.6/day · Month +21% — Mega-cap workflow software that just keeps grinding higher on AI-agent narrative. Relative strength velocity is the fastest in our Phase 2 group. Volume confirmation is light today (rVol 0.77) but the multi-day slope is positive, which is what matters. The setup: clean ladder higher, not a vertical move. Risk is rotation out of mega-cap software back into semis, which is the dominant flow direction right now.
**Agilysys (AGYS)** · Application Software · RS 96 · Vel +4.1/day · Month +29% — Small-cap hospitality software with the strongest fundamentals in the Phase 2 group (revenue accelerating, EPS surprise pattern). Higher beta than IBM or NOW — when this one moves, it moves harder in both directions. Position size accordingly. Phase 2 entry is clean, volume slope positive across the lookback.
**Gen Digital (GEN)** · Infrastructure Software · RS 89 · Vel +3.7/day · Month +31% — Cybersecurity consolidator (NortonLifeLock + Avast). Strong revenue and EPS momentum. The cyber sub-sector inside Infrastructure Software is heating up alongside Palo Alto and Fortinet, but Gen Digital hasn’t gone vertical yet. Phase 2 ENTRY classification with fundamentals to match — rare combo.
**Dexcom (DXCM)** · Medical Devices · RS 92 · Vel +4.2/day · Month +15% — Non-tech diversifier. CGM (continuous glucose monitoring) leader benefiting from GLP-1 patient overlap and Medicare reimbursement tailwinds. Strong FQ score. Volume slope positive across the 20-day window. If you’re already long IBM/NOW/AGYS and want non-correlated exposure, this is it.
> **Cautions on this list:** ENPH (Enphase) and GH (Guardant) ranked into Phase 2 ENTRY but both are already +33% to +71% on the month — late-cycle entries. INOD (Innodata) has perfect fundamentals (FQ 30) but the stock is up +129% in 30 days — it’s in mania, not entry. Skip these for new positions.
## The Quiet Beats
**Workday (WDAY)** · Application Software · RS 77 · Vel +3.7/day · Month +13% · FQ 22 — Cleanest Phase 1 stealth setup. Climbing without the mania premium, decent fundies, building base above the 50-day. Watch for a relative strength push above 80 to confirm the regime transition.
**V2X Inc (VVX)** · Aerospace & Defense · RS 74 · Vel +3.1/day · Month +12% · FQ 27 — Highest FQ score in the entire stealth list. Government-services defense contractor with revenue and earnings inflection. Aerospace & Defense industry is firing (TQ RS 87, +4% month) but VVX is still in the building phase. Quiet absorption setup.
**Valaris (VAL)** · Oil & Gas Equipment · RS 70 · Vel +6.0/day · Month +6% · FQ 20 — Fastest relative strength velocity in the entire scan. Coming off a low RS base (= more room before extended) with respectable fundamentals. Drilling-services revival play. If you want energy exposure that isn’t already up 30%, this is the cleanest entry geometry.
**Tactile Medical (TCMD)** · Medical Devices · RS 76 · Vel +3.4/day · Month +3% · FQ 25 — Lymphedema device maker with strong fundamentals, low monthly extension (+3%), and quietly building RS. Specialty medtech that nobody’s talking about — exactly the Phase 1 profile.
**Guidewire Software (GWRE)** · Application Software · RS 75 · Vel +3.3/day · Month +5% · FQ 24 — Insurance-vertical SaaS migration play. Long-duration thesis (Property & Casualty insurers slowly moving off mainframes) backed by strong recent fundamentals. Watch a close above the recent base for the Phase 2 trigger.
> **Pattern callout:** The Quiet Beats section today is dominated by **medium-RS (70-80) names with FQ 20+ scores**. These are the next leg of the rotation — the names that haven’t yet rerated but have the fundamental backing to support a move. Phase 2 mortality rate is high when the broader sector has already mania’d; Phase 1 names *in adjacent industries* are statistically more durable two-week trades.
## Yesterday’s Lessons
**HIMX absorption fired Day 2, not Day 4-6** — Our 5/11 watchlist promotion got the entry signal on a structurally raised guide. Pattern: when an earnings print delivers EPS doubling or revenue acceleration in the forward guide, the R10.1 second-entry window contracts to Day 1-2 instead of Day 4-6. Institutions don’t wait for the shakeout when the guide tells them the next quarter is already locked.
**DAVE and MNTN elevated-bar setups both killed** — Stocks running +50%+ INTO a print need a blowout-and-raise, not just a beat. Both names posted decent prints but in-line forward guides; both gapped down -4% to -8% on the day after. Lesson banked: pre-print run length is now a hard filter on watchlist additions.
**Semiconductors went from “warming” to “mania” in 14 sessions** — On 5/8 the top-quartile RS was 88 with month +18%. Today it’s 97 with month +37%. That’s the speed of regime transition. The rotation play is no longer adding to semis — it’s identifying the *next* cluster (Computer Hardware, Comm Equipment, IT Services) that’s six weeks behind on the same curve.
## The Read
**Best risk-adjusted trade today:** IBM. Phase 2 ENTRY confirmed, volume institutional (rVol 3.5x), mega-cap stability, only +13% on the month means the move is not extended. Mainframe-meets-AI is a real cash-flow story underneath the narrative.
**Highest-upside speculative trade:** AGYS (Agilysys). Small-cap, fundamentally clean, Phase 2 ENTRY with the strongest velocity in the high-FQ group. Higher beta — size smaller — but if Application Software extends its run, this is one of the names that moves multiples.
**Best two-week compounding trade:** VVX (V2X) and WDAY (Workday). Both are Phase 1 STEALTH with FQ scores in the 22-27 range — fundamental backing without the late-cycle extension. The Phase 1 to Phase 2 transition is where the cleanest 10-15% trades live.
**Don’t chase:** Semiconductors as a group. ALMU, AMBQ, MXL, MRAM — all up 100%+ on the month. The institutional rotation into this cluster started six weeks ago and has now finished. Adding here is paying retail prices on a Phase 3 cohort.
**Hard exclusions from any top call:** SMCI, QUBT, PACS. All three appear in today’s screener with strong relative strength. All three have confirmed governance failures — auditor resignations, validated short-seller reports, restatements, federal investigations. Strong-looking numbers from companies whose own auditors won’t sign off are not investable, regardless of the chart. Read once, internalize, never recommend.
**Lesson banked:** When a sector top-quartile RS goes from 85 to 95+ in two weeks while monthly performance hits +30%+, the rotation is over for new entries. Look for the *adjacent* industry that’s six weeks behind on the same arc.
---
**Not financial advice.** This is independent market analysis and momentum research, not a recommendation to buy or sell anything. Markets are volatile, individual securities can lose 100% of their value, and past performance does not predict future results. Do your own due diligence, size positions you can afford to lose, and consult a licensed financial advisor before making investment decisions. Your money, your risk, your call.